Lunate Capital
Latest statistics and disclosures from Lunate Capital's latest quarterly 13F-HR filing:
- Top 5 stock holdings are RVMD, SAIL, LINE, NMRA, NAVN, and represent 99.33% of Lunate Capital's stock portfolio.
- Reduced shares in these 1 stock: RVMD (-$160M).
- Lunate Capital was a net seller of stock by $-160M.
- Lunate Capital has $120M in assets under management (AUM), dropping by -54.45%.
- Central Index Key (CIK): 0002056786
Tip: Access up to 7 years of quarterly data
Positions held by Lunate Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Lunate Capital
Lunate Capital holds 6 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Revolution Medicines (RVMD) | 44.4 | $53M | -75% | 549k | 97.25 |
|
| Sailpoint (SAIL) | 33.0 | $40M | 3.0M | 13.24 |
|
|
| Lineage (LINE) | 16.3 | $20M | 600k | 32.76 |
|
|
| Neumora Therapeutics (NMRA) | 3.4 | $4.1M | 2.1M | 1.95 |
|
|
| Navan Cl A (NAVN) | 2.2 | $2.6M | 200k | 13.24 |
|
|
| Revolution Medicines *w Exp 12/17/202 (RVMDW) | 0.7 | $806k | 450k | 1.79 |
|
Past Filings by Lunate Capital
SEC 13F filings are viewable for Lunate Capital going back to 2025
- Lunate Capital 2026 Q1 filed April 16, 2026
- Lunate Capital 2025 Q4 filed Jan. 23, 2026
- Lunate Capital 2025 Q3 restated filed Nov. 20, 2025
- Lunate Capital 2025 Q2 filed July 17, 2025
- Lunate Capital 2025 Q1 filed April 25, 2025